Elekta, Inc. MOSAIQ Oncology Information System Recall
Hazard assessment based on recall description.
This AI-generated summary is provided for general informational purposes only and is derived from publicly available recall notices. It supplements but does not replace official agency classifications or safety instructions.
Check Your Product
According to the U.S. Food and Drug Administration (FDA)
Product
MOSAIQ Oncology Information System
Brand
Elekta, Inc.
Lot Codes / Batch Numbers
MOSAIQ 2.83 when run with First Data Bank (FDB), UDI/GTIN MOSAIQ 2.83 (0858164002367)
Products Sold
MOSAIQ 2.83 when run with First Data Bank (FDB), UDI/GTIN MOSAIQ 2.83 (0858164002367)
Elekta, Inc. is recalling MOSAIQ Oncology Information System due to A drug strength in MOSAIQ can be changed during the ordering process and approved, but the saved drug strength reverts to the original value.. Based on FDA medical device recall database.
Summary derived from FDA notice
Reason for Recall
As stated by FDA
A drug strength in MOSAIQ can be changed during the ordering process and approved, but the saved drug strength reverts to the original value.
Recommended Action
Per FDA guidance
The recalling firm issued an "URGENT IMPORTANT FIELD SAFETY NOTIFICATION" dated August 2021 via email to its consignees on 9/2/2021. Recommendations were made to the user until a fix is available.
Verify this information on the official source
For complete details and official instructions, check the U.S. Food and Drug Administration (FDA) directly.
View official FDA recall noticeDistribution
As reported by FDA
CA, CO, FL, ID, LA, MS, MO, NV, NH, NM, NY, NC, OH, OK, PA, SD, WA
Page updated: Jan 10, 2026